METHODS AND ANALYSIS

Study approval and registration
Written informed consent will be obtained from all patients. Oral consent -i.e., by nodding the head down and up to agree or nodding horizontal to disagree-will be obtained only from patients unable to draw the written consent. This procedure will be performed always in the presence of a witness (i.e., nurse or doctor). Afterwards, when the patient is able to write, the consent will be confirmed in writing. Unconscious patients and patients unable to follow the study information and thus to express their willingness will be excluded from the study. All procedures will be performed in accordance with the ethical standards of the institutional review board of the UZ/KU Leuven and with the 1964 Helsinki declaration and its later amendments.
Ethics approval has been obtained from the responsible local ethical committee (Ethische Commissie Onderzoek UZ/KU Leuven protocol ID: S60516).
Peripheral circulation measured by near infrared spectroscopy
Blood flow index (BFI) will be measured by near-infrared spectroscopy (NIRS, HAMAMATSU Photonics KK) in combination with injections of the tracer indocyanine green dye (ICG) 1 (NIRS-ICG). Since its first description in 1977, NIRS has become an extensively used method for non-invasive monitoring the changing levels of chromophores in the exercising muscles and brain tissue, namely, oxygenated, deoxygenated and total haemoglobin. 2 NIRS also enables detection of other chromophore tracers with absorption properties in the nearinfrared spectrum. 2 ICG that is widely used as hemodynamic tracer elicits an absorption peak at 805 nm 3 and, following intravenous infusion, is restricted to the intravascular compartment by >95% binding to plasma proteins. 4 ICG is water solube, nontoxic, and serious adverse reactions are extremely rare 5 , though it may interfere with thyroid function studies due to the presence of iodide in the dye. 6 For that reason, its use is inadvisable in subjects with an iodine allergy or thyreotoxicosis. In extremely rare cases, an ICG injection can cause an anaphylactic reaction (incidence of approximately 1:40,000), the principal manifestations being pruritus, urticaria, tachycardia, hypotension, dyspnoea and shortness of breath. 5 ICG is completely excreted by the liver and is cleared from the human circulation with a half-time of 3.2 ± 0.6 to 3.4 ± 0.7 minutes thus making ICG a suitable tracer for repetitive measurements even at short intervals without accumulation of dye. Maximal daily dosage should not exceed 2-5 mg/kg (product information ICG-Pulsion; Pulsion Medical Systems). According to the study design the number of ICG injections that will be performed in each patient will not exceed the number of three (maximum amount of injectable 15 mg) whilst each injection will contain 5 mg of ICG dissolved in 1 ml of sterile water (5mg/mL) followed by a rapid 10-ml flush of isotonic saline.
NIRS-ICG derived BFI as relative measurement of local tissues perfusion will be calculated by dividing the muscle ICG peak concentration (assessed by NIRS-ICG curve) by the rise time from 10 to 90% of peak. 7 The use of these two cut-off points eliminates the need for exact temporal definition of the start and end of the ICG wash in thus reducing the possibility of observer errors. 8, 9 In addition, by using this model, it has been shown that 99% of a tracer can be absorbed by the capillaries, indicating no back flux. 10 NIRS-ICG derived BFI, is valid and reproducible in detecting relative perfusion differences in respiratory (both inspiratory and expiratory muscles) and locomotor muscles of patients with chronic lungs diseases and in cerebral cortex blood flow during bedside assessment in patients with acute ischemic stroke or patients requiring MV. 1, 2, 7, 11, 12 To measure cerebral cortex and respiratory muscle BFI, three sets of NIRS optodes (will be transcutaneously positioned as follows: for the brain over the prefrontal cortex area (at an adequate distance to avoid interference with the midline sinus, which may cause readings nonreflective of brain tissue) 13 , for the inspiratory muscle on the scalene muscles, for the expiratory muscle on the upper rectus abdominis. An additional probe (4th) will be placed on thenar eminence muscle representing a non-working muscle group. [14] [15] The probes will be fixed using a double-sided adhesive tape and will be secured by using an adhesive dressing (Cosmopor 6.5
x 3.8 cm, Hartmann AG, Germany). A pathlength of 24.0 cm of cerebral cortex and 18.0 cm for both respiratory and thenar muscle will be set up according to the manufacturer's recommendations. Separation distance between the NIRS light transmitter and receiver probes will 40 mm, thus allowing a maximum NIRS penetration depth of 20 mm. In this context, with regard to cerebral cortex NIRS measures, it has been documented that by injecting ICG directly into the internal carotid artery, near-infrared light can penetrate through human scalp and skull into the brain, undergo attenuation of near-infrared light in the cerebral vascular compartment thus providing that NIRS can sufficiently detect changes incerebral optical properties [16] [17] . In addition, studies that have compared right and left frontal cerebral cortex TOI values, showing that there is no significant difference from side to side. 18, 19 ICG concentration curves data will be exported by NIRS in document file format (i.e., filename extension .txt) and stored on disk for off-line analysis. Unfortunately, NIRS cannot measure blood flow of the diaphragm and as such giving us the opportunity to provide a more complete picture of perfusion redistribution of the main inspiratory muscle. This is due to the substantial distance between the sampling point of NIRS on the skin and the diaphragmatic appositional area compared with the shorter distance for the scalene and abdominal muscles. An additional probe (4th) will be placed on thenar eminence muscle representing a non-working muscle group with very good response to NIRS signal. [14] [15] ICG concentration curves data will be exported by NIRS in document file format (i.e., filename extension .txt) and stored on disk for off-line analysis. ICG concentration curves in .txt format will be analysed by using the Chart5 version 5.4.2 (ADInstruments) program. 1 Typically the original ICG tracing appears with marked oscillations because of muscle contraction and relaxation during breathing (Figure 3 , right panel) thus making difficult to accurately identify the peak ICG concentration. To this end, low-pass filtering with a cut-off frequency of 0.5 Hz and smoothing window width (by using the triangular Bartlett window function) of 9 points will be used to smooth the ICG curves for blood flow index (BFI) calculation. 1 NIRS data will be sampled at 6 Hz.
Peripheral oxygenation measured by near infrared spectroscopy
Continues measurements of tissues oxygenation (TOI) will be performed by NIRS. NIRSderived TOI is a real-time and rapidly responsive absolute index of fractional local tissue oxygenation. This non-invasive index is the ratio of microvascular oxygenated (HbO2) to total tissue hemoglobin concentration (tHbO2) expressed as percentage [(HbO2/ tHbO2) * 100] and reflects the dynamic balance between local tissue oxygen supply and utilization 20 and therefore tissue capacity to match oxygen supplies relative to its metabolic demands. 21 Tissues oxygenation will be assessed by the same spectrophotometer as used for the measurement of BFI. Data analysis in terms of data smoothing will follow the same procedure as described for BFI calculation. Due to high ICG tissue concentrations during the passage of the dye bolus through the tissue may interfere with Hb signals and TOI data and thus TOI variable will be averaged over 60 seconds immediately before ICG injection.
Hemodynamic status
Cardiac output will be assessed continuously by pulse contour analyses using a sensor (Pulsioflex Monitor, Pulsion Medical Systems SE). 22 Utilizing an existing peripheral arterial catheter for arterial blood pressure and analyzing the arterial waveform 250 times per second, a start value for cardiac output trend monitoring is determined after the patient's characteristics are inserted to the system. Pulse pressure analysis is based on the hypothesis that the stroke volume is proportional to the arterial pulse pressure. 23 By using a specific algorithm 23 taking into account that the compliance of the aortic wall is affected by age and inversely related to aortic wall pressure changes, the device calculates the stroke volume by integrating the area under the curve of the systolic phase of the arterial waveform. Then the calculation of cardiac output is performed beat-by-beat by simply multiplying the stroke volume with the heart rate that is also simultaneously recorded. 22 The arterial pressure waveform analysis method has been extensively investigated against cardiac output calculations using clinical gold-standard methods. [24] [25] [26] [27] [28] [29] [30] The results of these studies indicate that pulse contour analyses -without calibration-method can provides clinically acceptable cardiac output trend assessment particularly in hemodynamically stable patients. Cardiac output data will be exported beat-by beat, in document file format (i.e., filename extension .txt) and stored on disk for off-line analysis. Cardiac output and heart rate data will be averaged over 60 seconds during each BFI determination. 
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